A detailed history of Financial Advisors Network, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Financial Advisors Network, Inc. holds 16,148 shares of EW stock, worth $1.06 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
16,148
Previous 16,148 -0.0%
Holding current value
$1.06 Million
Previous $1.12 Million 10.11%
% of portfolio
0.25%
Previous 0.25%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $29,582 - $39,873
427 Added 2.72%
16,148 $1.12 Million
Q4 2022

Feb 02, 2023

BUY
$68.3 - $87.44 $194,450 - $248,941
2,847 Added 22.11%
15,721 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $12,932 - $16,844
157 Added 1.23%
12,874 $1.06 Million
Q2 2022

Aug 04, 2022

SELL
$86.5 - $128.27 $7,266 - $10,774
-84 Reduced 0.66%
12,717 $1.21 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $43,434 - $54,672
-426 Reduced 3.22%
12,801 $1.51 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $120,517 - $148,060
1,133 Added 9.37%
13,227 $1.71 Million
Q3 2021

Dec 27, 2021

SELL
$102.91 - $122.75 $3,601 - $4,296
-35 Reduced 0.29%
12,094 $1.4 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $25,319 - $31,637
-302 Reduced 2.43%
12,129 $1.26 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $499,792 - $668,387
8,686 Added 231.94%
12,431 $859,000
Q1 2019

Jun 04, 2019

SELL
$47.89 - $64.05 $4,310 - $5,764
-90 Reduced 2.35%
3,745 $639,000
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $2,320 - $2,847
50 Added 1.32%
3,835 $587,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $8,192 - $9,900
-193 Reduced 4.85%
3,785 $551,000
Q4 2017

Feb 07, 2018

BUY
$33.79 - $39.39 $270 - $315
8 Added 0.2%
3,978 $448,000
Q3 2017

Nov 15, 2017

BUY
$36.29 - $38.83 $144,071 - $154,155
3,970
3,970 $434,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Financial Advisors Network, Inc. Portfolio

Follow Financial Advisors Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors Network, Inc. with notifications on news.